ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Hammersmith Medicines Research Limited

Hammersmith Medicines Research Limited is an active company incorporated on 15 January 1993 with the registered office located in London, Greater London. Hammersmith Medicines Research Limited was registered 33 years ago.
Status
Active
Active since incorporation
Company No
02779946
Private limited company
Age
33 years
Incorporated 15 January 1993
Size
Medium
Turnover is under £54M
Balance sheet is under £27M
Confirmation
Due Soon
Dated 15 January 2025 (11 months ago)
Next confirmation dated 15 January 2026
Due by 29 January 2026 (19 days remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Feb31 Jan 2024 (12 months)
Accounts type is Group
Next accounts for period 31 July 2025
Due by 30 April 2026 (3 months remaining)
Contact
Address
44 Cumberland Avenue
London
NW10 7EW
Same address for the past 11 years
Telephone
02089614130
Email
Available in Endole App
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Canadian • Lives in Canada • Born in May 1972
Director • Australian • Lives in Australia • Born in Sep 1974
NN Bidco Pty Ltd (Acn 623 536 247)
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Brands
Hammersmith Medicines Research Ltd
Hammersmith Medicines Research Ltd is a Clinical Research Organisation (CRO) that focuses on early phase clinical trials for pharmaceutical and biotechnology companies.
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Jan 2024
For period 31 Jan31 Jan 2024
Traded for 12 months
Cash in Bank
£3.74M
Increased by £1.75M (+88%)
Turnover
£21.48M
Increased by £862K (+4%)
Employees
291
Decreased by 17 (-6%)
Total Assets
£28.37M
Decreased by £688K (-2%)
Total Liabilities
-£4.71M
Increased by £42K (+1%)
Net Assets
£23.66M
Decreased by £730K (-3%)
Debt Ratio (%)
17%
Increased by 0.54% (+3%)
Latest Activity
Accounting Period Extended
2 Months Ago on 28 Oct 2025
Malcolm James Boyce (PSC) Resigned
5 Months Ago on 1 Aug 2025
Nn Bidco Pty Ltd (Acn 623 536 247) (PSC) Appointed
5 Months Ago on 1 Aug 2025
Steven John Warrington Resigned
5 Months Ago on 1 Aug 2025
Malcolm James Boyce Resigned
5 Months Ago on 1 Aug 2025
Graham Keith Wood Appointed
5 Months Ago on 1 Aug 2025
Teena Joy Pisarev Appointed
5 Months Ago on 1 Aug 2025
Group Accounts Submitted
7 Months Ago on 21 May 2025
Charles Kevin O'brien Resigned
11 Months Ago on 31 Jan 2025
Confirmation Submitted
11 Months Ago on 17 Jan 2025
Get Credit Report
Discover Hammersmith Medicines Research Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Previous accounting period extended from 31 January 2025 to 31 July 2025
Submitted on 28 Oct 2025
Cessation of Malcolm James Boyce as a person with significant control on 1 August 2025
Submitted on 6 Aug 2025
Notification of Nn Bidco Pty Ltd (Acn 623 536 247) as a person with significant control on 1 August 2025
Submitted on 6 Aug 2025
Termination of appointment of Steven John Warrington as a director on 1 August 2025
Submitted on 6 Aug 2025
Termination of appointment of Malcolm James Boyce as a director on 1 August 2025
Submitted on 6 Aug 2025
Appointment of Graham Keith Wood as a director on 1 August 2025
Submitted on 6 Aug 2025
Appointment of Teena Joy Pisarev as a director on 1 August 2025
Submitted on 6 Aug 2025
Group of companies' accounts made up to 31 January 2024
Submitted on 21 May 2025
Termination of appointment of Charles Kevin O'brien as a secretary on 31 January 2025
Submitted on 31 Jan 2025
Confirmation statement made on 15 January 2025 with no updates
Submitted on 17 Jan 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year